| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $103.88M | - | |
| Dir | 1.55M | $82.12M | - | |
| Dir | 1.19M | $62.87M | - | |
| CFO | 1.12M | $59.07M | - | |
| VP | 594.7K | $31.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 1,000 | $24.04 | $24,040.00 | -1.1% | |
| Apr 10, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $24.06 | $962,400.00 | -30.8% | |
| Apr 3, 2019 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 63,109 | $25.00 | $1,577,725.00 | -16.6% | |
| Apr 3, 2019 | Scangos George A77 | Director | Sell | 45,000 | $24.13 | $1,085,950.00 | -1.7% | |
| Apr 1, 2019 | Hessekiel Jeffrey54 | EVP And General Counsel | Sale+OE | 20,000 | $24.03 | $480,600.00 | -7.9% | |
| Apr 1, 2019 | Garber Alan M50 | Director | Sale+OE | 30,000 | $23.99 | $719,550.00 | -19.7% | |
| Apr 1, 2019 | Wyszomierski Jack L | Director | Sale+OE | 7,822 | $23.97 | $187,493.34 | -6.1% | |
| Mar 29, 2019 | Poste George | Director | Sale+OE | 3,860 | $23.89 | $92,215.40 | -3.6% | |
| Mar 27, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $23.39 | $935,600.00 | -30.8% | |
| Mar 26, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sale+OE | 2,700 | $23.47 | $63,369.00 | -2.9% |